Randomized Double-blind Placebo-controlled Trial on Levothyroxine and Liothyronine Combination Therapy in Totally Thyroidectomized Subjects: the Levolio Study

CONCLUSIONS: Six months of combination therapy with twice daily LT3 dose adapted according to TSH-level do not significantly change peripheral tissue response or quality of life, despite an increase in the fT3/fT4 ratio.PMID:38124252 | DOI:10.1093/ejendo/lvad172

Source: European Journal of Endocrinology - December 21, 2023 Category: Endocrinology Authors: Brigante Giulia Santi Daniele Boselli Gisella Margiotta Gianluca Corleto Rossella Monzani Maria Laura Craparo Andrea Locaso Michela Sperduti Samantha Roy Neena Casarini Livio Trenti Tommaso Tagliavini Simonetta De Santis Maria Cristina Roli Laura Rochira Source Type: research